Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

QR678 and QR678 Neo treatments, combined with corticosteroid injections, work better for alopecia areata than corticosteroid injections alone.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Targeting CD169+ skin macrophages may help treat psoriasis.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

Removing anthrax toxin receptor 1 in pigs prevents Senecavirus A infection and causes a rare disease similar to GAPO syndrome.

CD18-deficient mice developed psoriasis-like skin disease, useful for studying inflammatory skin disorders.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

Toll-like receptor 3 helps repair the skin barrier after UV damage.

Deleting Crif1 in mouse skin disrupts skin balance and hair growth.

Females are more prone to lupus and arthritis due to X chromosome factors.

IL-18 signaling helps mature Tregs move into the thymus.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Deleting the Trf1 protein in mice is safe and may help prevent cancer without major side effects.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Anti-Desmocollin 3 antibodies can cause atypical pemphigus symptoms.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Abrocitinib may effectively treat stubborn alopecia universalis.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.